🇺🇸 FDA

Drug profile · INN

rozanolixizumab

RYSTIGGO

EMA: approved L04AL02
Patents linked
0
News articles
0

Quick answer

rozanolixizumab (RYSTIGGO) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN rozanolixizumab
Brand RYSTIGGO
ATC code L04AL02

Frequently asked questions

What is rozanolixizumab?

rozanolixizumab (RYSTIGGO) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for rozanolixizumab?

RYSTIGGO is a marketed brand name for rozanolixizumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.